Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
2.49M
-
Shares change
-
-66.3K
-
Total reported value, excl. options
-
$177M
-
Value change
-
-$8.58M
-
Number of buys
-
54
-
Number of sells
-
-41
-
Price
-
$71.11
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q1 2024
109 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q1 2024.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.49M shares
of 3.2M outstanding shares and own 77.71% of the company stock.
Largest 10 shareholders include FMR LLC (393K shares), RENAISSANCE TECHNOLOGIES LLC (233K shares), BlackRock Inc. (214K shares), VANGUARD GROUP INC (183K shares), DIMENSIONAL FUND ADVISORS LP (162K shares), STATE STREET CORP (80.7K shares), Ranger Investment Management, L.P. (80.4K shares), GEODE CAPITAL MANAGEMENT, LLC (73.7K shares), JPMORGAN CHASE & CO (72.6K shares), and BRANDES INVESTMENT PARTNERS, LP (70.1K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.